SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?


To: Jim Roof who wrote (429)11/10/1997 12:24:00 PM
From: Pseudo Biologist  Read Replies (1) | Respond to of 1972
 
Jim, I saw the piece in the local paper (San Jose Merc), and it did sound a lot like what Merck is/will be doing with Vical's technology on VEGF. Neither company was mentioned. Here is a link to a version of the story that covers a second study that does NOT seem to involve VEGF.

eurekalert.org

PB